• ACCELERATE

    Innovation in therapies for children and adolescents with cancer


    OUR NAME IS OUR MISSION!

    Find out more

WHY ACCELERATE?

children and adolescents are diagnosed with cancer each year worldwide. 50,000+ only in EU and US combined

die out of this condition in Europe each year. 15 EVERY DAY

Cause of death by disease in children >1 year in high-income countries

of children with cancer resistant to conventional treatment die

of delay until the same new medicine already approved for adults gets approved for children

long-term survivors of childhood cancer live in Europe today. 2/3 of them experience long-term health related problems

HOW TO ACCELERATE

  • ALADDIN: the new educational program on strategic and regulatory science in paediatric oncology drug development


    Find out more
  • FAIR trials

    Fostering Age Inclusive Research (FAIR) Trials

    To improve access for adolescents to new anti-cancer drugs and to make the drug development process more efficient

    Find out more
  • ACCELERATE Publications

    ACCELERATE Publications


    Find out more

NEWS

request-appointmnet

Annual Conference


5 - 6 February 2026
Brussels



Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer – An ACCELERATE Multistakeholder Consensus


ASCPT

De Rojas, T. et al.

November 2023

Read it now